ZetrOZ, Inc. Report issue

For profit Phase 2
Founded: Trumbull Connecticut United States (2009)

Organization Overview

First Clinical Trial
2019
NCT04391842
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

ZetrOZ, Inc. | ZetrOZ Systems

Active Ingredients

Drugs in Phase 2 Trials (1)

diclofenac (voltaren) (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 1)

Osteoarthritis (Phase 1)

Osteoarthritis, Knee (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 1